Wernau Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$479K Hold
414
– – 0.22% 32
2026
Q2
$497K Sell
414
-22
-5% -$22.5K 0.26% 33
2026
Q1
$401K Hold
436
– – 0.28% 35
2025
Q4
$469K Hold
436
– – 0.25% 33
2025
Q3
$333K Hold
436
– – 0.23% 37
2025
Q2
$340K Buy
436
+10
+2% +$7.77K 0.24% 36
2025
Q1
$352K Hold
426
– – 0.28% 36
2024
Q4
$329K Hold
426
– – 0.25% 43

Other funds holding LLY

Wernau Asset Management's LLY Position: Q3 2026 in Review

Wernau Asset Management held its Eli Lilly (LLY) position steady in Q3 2026 at 414 shares worth $479K. The position accounts for 0.22% of the portfolio, ranked #32.

Wernau Asset Management first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $497K in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Wernau Asset Management held 414 shares of Eli Lilly worth $479K as of Q3 2026.
  • Wernau Asset Management left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.22% of Wernau Asset Management's portfolio in Q3 2026, its #32 holding.
  • Wernau Asset Management first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • Wernau Asset Management's Eli Lilly position peaked at $497K in Q2 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Wernau Asset Management's 13F filing for Q3 2026, filed 19 Oct 2026.